Provided by Tiger Trade Technology Pte. Ltd.

Legend Biotech

16.80
-0.6900-3.95%
Post-market: 16.810.0100+0.06%19:18 EDT
Volume:1.31M
Turnover:22.32M
Market Cap:3.10B
PE:-10.37
High:17.69
Open:17.65
Low:16.76
Close:17.49
52wk High:45.30
52wk Low:16.24
Shares:184.69M
Float Shares:81.38M
Volume Ratio:1.06
T/O Rate:1.61%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6200
EPS(LYR):-1.6200
ROE:-29.06%
ROA:-5.01%
PB:3.10
PE(LYR):-10.37

Loading ...

RBC Cuts Price Target on Legend Biotech to $62 From $66, Keeps Outperform Rating

MT Newswires Live
·
Mar 11

Genscript Flags Legend Biotech’s 2025 Results, Cautions Investors on Risk

TIPRANKS
·
Mar 10

Legend Biotech Q4 revenue slightly misses; expects operating profit in 2026

Reuters
·
Mar 10

Earnings Flash (LEGN) Legend Biotech Posts Q4 Loss $0.08 a Share, vs. FactSet Est of $0.02 EPS

MT Newswires Live
·
Mar 10

Legend Biotech Q4 Adj. EPS $0.01 Beats $(0.11) Estimate, Sales $306.300M Miss $306.875M Estimate.

Benzinga
·
Mar 10

BRIEF-Legend Biotech Corporation Q4 EPS USD -0.08

Reuters
·
Mar 10

Legend Biotech Corporation Q4 Revenue USD 306.3 Million VS. Ibes Estimate USD 306.9 Million

THOMSON REUTERS
·
Mar 10

Legend Biotech Corporation Q4 Pretax Profit USD -19.7 Million

THOMSON REUTERS
·
Mar 10

Legend Biotech Reports Fourth Quarter and Full Year 2025 Results and Recent Highlights

GlobeNewswire
·
Mar 10

U.S. Earnings Preview: Before Market Open March 10

Dow Jones
·
Mar 10

Legend Biotech (LEGN) Receives a Buy from Barclays

TIPRANKS
·
Mar 10

Legend Biotech Corp expected to post a loss of 11 cents a share - Earnings Preview

Reuters
·
Mar 06

Oppenheimer Reaffirms Their Buy Rating on Legend Biotech (LEGN)

TIPRANKS
·
Mar 06

Earning Preview: Legend Biotech Q1 revenue is expected to increase by 71.50%, and institutional views are cautiously optimistic

Earnings Agent
·
Mar 03

Legend Biotech Corporation to Host Investor Conference Call on Fourth-Quarter and Full-Year 2025 Results

Reuters
·
Feb 24

Legend Biotech: Undervalued BCMA CAR-T Leader with Lower Commercial Risk and DCF-Supported Upside to $50 Target

TIPRANKS
·
Feb 24

Legend Biotech rises 16.6%

TIPRANKS
·
Feb 23

Legend Biotech Shares Lower After Rothschild & Co Redburn Downgrade

MT Newswires Live
·
Feb 13

Rothschild & Co Redburn Downgrades Legend Biotech to Neutral From Buy

MT Newswires Live
·
Feb 12

Legend Biotech Names Veteran Finance Executive Gareth Kung to Board and Audit Chair Role

TIPRANKS
·
Feb 07